Navigation Links
Hospira and Lancaster General Hospital Honored for Patient Safety Initiatives
Date:6/29/2012

LAKE FOREST, Ill., June 29, 2012 /PRNewswire/ -- Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, today announced that Hospira and Lancaster General Hospital have been selected as the 2012 co-recipients of the Association for the Advancement of Medical Instrumentation (AAMI) Foundation/Institute for Technology in Health Care Clinical Application Award. Given annually to an individual or group that has applied innovative clinical engineering practices or principles to help solve significant clinical patient care problems or challenges, this award honored Hospira and Lancaster for implementing an automated smart infusion system at the patient bedside. Hospira and Lancaster General Hospital accepted the award at the AAMI Annual Conference & Expo earlier this month.

Lancaster became one of the first institutions to move I.V. interoperability, or I.V. clinical integration, of smart infusion pumps with the electronic health record (EHR), beyond a pilot phase. They worked with Hospira and their information technology partners to implement the integrated system using Plum A+™ infusion pumps with Hospira MedNet™ safety software connected to the hospital information system. Using I.V. clinical integration to link a smart pump with EHRs helps hospitals enhance safety and efficiency and avoid costs.

Following their initial implementation of I.V. clinical integration technology, Lancaster General Hospital saw a 32 percent reduction in reported monthly errors involving I.V. medication administration. Additionally, the hospital saw a streamlined workflow for pump programming, reducing the number of programming steps by 58.8 percent (from 17 to 7).(1)

"At Lancaster General Hospital, we strive to eliminate medication errors through continuous process improvements," said Richard Paoletti, vice president, Lancaster General Hospital. "We are proud to be recognized as a leader of smart pump and EHR integration to help streamline the I.V. medication process and reduce error potential."

"As the leader in infusion technologies and I.V. clinical integration, Hospira is committed to delivering quality technology and services to our customers across our entire smart pump offering," said Richard Nevin, vice president, Medication Management Systems, U.S., Hospira. "Hospira and Lancaster have a shared vision of advancing health and wellness, which we're proud to have achieved through this advanced technology."

Hospira is leading the industry toward integration of healthcare technologies, which could dramatically reduce medical errors, and potentially save thousands of lives and avoid millions of dollars in costs due to medication errors. While adoption of EHRs is expanding rapidly, integration of EHRs with smart pumps and other devices is the critical next step in improving the accuracy and safety of medical care. More than an estimated 1.5 million preventable medication errors occur each year in the United States throughout the healthcare system, and medication errors add more than $3.5 billion per year to hospital costs.(2)

Near real-time sharing of information between EHR systems and smart pumps can help reduce the potential for medication errors by ensuring that all medications are tracked and validated between prescribing and administration to the patient. A recent KLAS report highlighted Hospira as the early leader in smart pump integration, with more live I.V. clinical integration sites than any other infusion pump provider and the only vendor to integrate with multiple EHR providers, including Cerner and Epic.(3)

About Hospira

Hospira, Inc. is the world's leading provider of injectable drugs and infusion technologies. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. The company is headquartered in Lake Forest, Ill., and has approximately 15,000 employees. Learn more at www.hospira.com.

About Lancaster General Health

Lancaster General Health (LG Health) is a 623-licensed bed not-for-profit health system with a comprehensive network of care encompassing Lancaster General Hospital (LGH) and Women & Babies Hospital, including a Level III-B Neonatal Intensive Care Unit, and a network of outpatient centers and physician practices. Thrice designated a Magnet hospital for nursing excellence, LGH has been recognized regionally and nationally for its cardiovascular, intensive care and orthopedic services. Other entities include LG College of Nursing & Health Sciences, Lancaster Rehabilitation Hospital, VNA Community Care Services, LG Health Research Institute and Lancaster Cleft Palate Clinic. In the summer of 2013, the new Ann B. Barshinger Cancer Center will provide advanced technology and integration of cancer care under one roof. As a member of the Penn Cancer Network, LG Health has access to the vast research and technological resources of one of the nation's foremost cancer centers.

 

(1) Prusch AE, Suess TM, Paoletti RD, Olin ST, Watts SD. Integrating technology to improve medication administration. Am J Health-Syst Pharm. 2011;68:835-842.

(2) Aspden P, Wolcott J, Bootman J, Cronenwett L, eds. Preventing Medical Errors: Quality Chasm Series. Washington DC: National Academies Press; 2007.

(3) "Smart Pumps 2012: Wireless Technology and EMR Integration," April, 2012. © 2012 KLAS Enterprises, LLC. All rights reserved. www.KLASresearch.com

 


'/>"/>
SOURCE Hospira, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care Conference
2. Hospira Reports First-Quarter 2012 Results
3. Hospira to Present at Upcoming Investor Conferences
4. I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process
5. ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report
6. Simcere Pharmaceutical Group Provides Notice of Annual General Meeting
7. Leading Pension Annuity Provider Legal & General, Celebrates 175 Years
8. Chesapeake Urologys Dr. Brad Lerner, Chief of Urology at Union Memorial Hospital, Honored with Governors Citation for Outstanding Service
9. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
10. National Jewish Health, the Nations Premier Respiratory Hospital, Announces Lung Cancer Screening Trial Using Blood Test and CT
11. Without Environmental Hygiene, Hand Hygiene Programs Fall Short in Reducing HAIs in Hospital Settings, Says UMF Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... April 20, 2017 Research and ... Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through ... their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production ... an in-depth assessment of the current trends in the ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... Inc ., a digital health company focused on modernizing and ... $25 million in Series B funding led by Qiming US ... Seattle that is part of a broader family ... included participation from SR One , who led ZappRx,s ... Google Ventures). As part of the financing, Mark McDade ...
Breaking Medicine Technology:
(Date:4/22/2017)... ... April 22, 2017 , ... ... has named PROSHRED® Security of Philadelphia its “Woman-Owned Small Business of ... specializes in providing information destruction , recycling, and compliance services to ...
(Date:4/22/2017)... ... 2017 , ... The San Juan Capistrano summer camp team at the Boys and ... for summer camps to provide physical activities for all campers. To read the report, ... , With an increase in specialty camps that focus on what the report terms as ...
(Date:4/21/2017)... ... , ... The staff at Palm Beach Face is proud to announce that their practice founder, ... Set to take place on April 23rd, the London Marathon has a long tradition of ... part of team EMPOWER, raising money for the international charity, Smile Train. , ...
(Date:4/21/2017)... CITY, Utah (PRWEB) , ... April 21, 2017 ... ... of wilderness therapy treatment for adolescents and young adults, has kicked off its ... 20th-Sunday, April 23rd. This year’s theme is “Attachment Informed Therapy for Mental ...
(Date:4/21/2017)... ... April 21, 2017 , ... Dudnyk has announced the launch of its ... that the full potential of specialty and orphan brands can only be achieved when ... , “The Unifying Effect is at the heart of a true partnership between our ...
Breaking Medicine News(10 mins):